In November, the New England Journal of Medicine published the Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine.
This phase 3, randomised, observer-blinded trial compared a quad…
The Modified mRNA Influenza Vaccine Trial - Part 1
The case definitions
